ZIOPHARM Oncology Inc

Please note: The information displayed on this page might be outdated.
ZIOPHARM Oncology Inc:
The company is focused on the development of two platform technologies designed to deliver safe, effective and scalable cell- and viral-based therapies for the treatment of multiple cancer types: (1) Controlled IL-12 for turning cold tumors hot and (2) Sleeping Beauty (SB) a non-viral approach to genetically modifying cells with significantly shortened manufacturing and lower COGS. Plan to submit an IND to evaluate SB-modified TCRs targeting neoantigens to treat solid tumors in Q4 2018 followed by enrollment of patients at the NCI beginning in 2019. Currently enrolling patients in a phase 1 trials of Ad-RTS-hIL-12 as monotherapy and in combination with OPDIVO for the treatment of rGBM.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - New England
Clinical Stage
Phase l or ll
Disease Space
Immuno-Oncology
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
500MM - 1B
Therapeutic Modalities
Cell Therapy, Platform Technology
Website:
Address:
1 1st Ave
#34
Charlestown, MA 02129
United States
#34
Charlestown, MA 02129
United States
More info:
My account:
Company Participants at Solebury Trout CEO & Investor Ski Conference 2020
- Laurence Cooper, MD, PhD, CEO
Top 10 Holders of ZIOPHARM Oncology, Inc.
Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
---|---|---|---|---|---|
The Vanguard Group, Inc. | 8.78 | 15,888,193 | 57.67 | Funds | 12/31/20 |
MSD Partners LP | 8.37 | 15,151,516 | 55.00 | Stakes | 10/29/20 |
Vanguard Group, Inc. (Subfiler) | 8.16 | 14,769,506 | 53.61 | 13F | 9/30/20 |
Miller Value Partners LLC | 6.84 | 12,385,586 | 44.96 | 13F | 9/30/20 |
Discovery Capital Management LLC | 6.07 | 10,994,728 | 39.91 | Stakes | 12/28/20 |
White Rock Capital Management LP | 5.32 | 9,627,879 | 34.95 | Stakes | 11/5/20 |
State Street Corp. | 5.21 | 9,436,633 | 34.25 | 13F | 9/30/20 |
BlackRock Fund Advisors | 4.04 | 7,316,194 | 26.56 | 13F | 9/30/20 |
BlackRock Institutional Trust Co. NA | 3.34 | 6,040,163 | 21.93 | 13F | 9/30/20 |
Geode Capital Management LLC | 1.63 | 2,959,235 | 10.74 | 13F | 9/30/20 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.